
Public Health
SHA Changes Cancer Treatment Approvals, Maintains KES 800,000 Benefit
SHA says new cancer treatment approval and pricing changes aim to standardise costs and protect patients, while the KES 800,000 oncology benefit remains unchanged.

SHA says new cancer treatment approval and pricing changes aim to standardise costs and protect patients, while the KES 800,000 oncology benefit remains unchanged.